Dovato 50-300 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9EM6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,687
Award facts
- Contract value 100% obligated
- $39,687.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency (DLA) on December 4, 2025, for the supply of Dovato 50-300 mg tablets (30-count units). The contract is valued at $39,687.23 with a firm fixed price structure and an ultimate completion date of December 5, 2025. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and runs through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical supplies to support military healthcare programs worldwide.
The award reflects AmerisourceBergen's established role as a critical vendor within the federal medical procurement infrastructure, particularly for Defense Health Agency and military healthcare systems. No set-aside designation was applied to this contract, indicating it was awarded through open competition. This specific delivery order for the antiretroviral medication Dovato represents one of many pharmaceutical product deliveries the company fulfills under its DLA master contract, demonstrating its capability to provide both specialty medications and routine pharmaceutical commodities across multiple therapeutic domains in support of federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F9EM6?
SPE2DR26F9EM6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26F9EM6 worth?
The government has obligated $39,687 on SPE2DR26F9EM6.
Is contract SPE2DR26F9EM6 an order under another contract?
Yes. SPE2DR26F9EM6 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9EM6 competed?
The extent of competition for SPE2DR26F9EM6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award